CP
PLSE icon

Corbenic Partners’s Pulse Biosciences PLSE Stock Holding History

Corbenic Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Hold
65
– – ﹤0.01% 237
2022
Q1 		$0 Hold
65
– – ﹤0.01% 272
2021
Q4 		$1K Hold
65
– – ﹤0.01% 268
2021
Q3 		$1K Hold
65
– – ﹤0.01% 269
2021
Q2 		$1K Hold
65
– – ﹤0.01% 245
2021
Q1 		$2K Hold
65
– – ﹤0.01% 224
2020
Q4 		$2K Sell
65
-65
-50% -$1.03K ﹤0.01% 176
2020
Q3 		$2K Hold
130
– – ﹤0.01% 148
2020
Q2 		$1K Hold
130
– – ﹤0.01% 151
2020
Q1 		$1K Hold
130
– – ﹤0.01% 175
2019
Q4 		$2K Buy
+130
New +$1.85K ﹤0.01% 162

Other funds holding PLSE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Corbenic Partners's PLSE Position: Q2 2022 in Review

Corbenic Partners held its Pulse Biosciences (PLSE) position steady in Q2 2022 at 65 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Corbenic Partners first reported a position in PLSE in Q4 2019 and has held it in 11 quarters since. The position peaked at $2K in Q1 2021. 44 funds tracked by Wall St. Rank hold PLSE as of Q2 2022.

  • Corbenic Partners held 65 shares of Pulse Biosciences worth $0 as of Q2 2022.
  • Corbenic Partners left its Pulse Biosciences share count unchanged in Q2 2022.
  • Pulse Biosciences made up ﹤0.01% of Corbenic Partners's portfolio in Q2 2022, its #237 holding.
  • Corbenic Partners first reported a position in Pulse Biosciences in Q4 2019 and has held it in 11 quarters since.
  • Corbenic Partners's Pulse Biosciences position peaked at $2K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.